Bonus BioGroup Ltd. (BBIXF)

OTCMKTS · Delayed Price · Currency is USD

0.0400

+0.0100 (33.33%)

At close: Sep 4, 2026

Market Cap	69.84M -22.8%
Revenue (ttm)	n/a
Net Income	-8.01M
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.0400
Previous Close	0.0300
Day's Range	0.0400 - 0.0400
52-Week Range	0.0003 - 0.1500
Beta	0.89
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Bonus BioGroup

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1981

Employees 42

Stock Exchange OTCMKTS

Ticker Symbol BBIXF

Financial Performance

Financial numbers in ILS Financial Statements